跳至主要内容
临床试验/NL-OMON55070
NL-OMON55070尚未招募不适用

trecht Health Project - Utrecht Cardiovascular Cohort (UHP-UCC) - UHP-UCC

niversitair Medisch Centrum Utrecht0 个研究点目标入组 800 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
800

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Being a participant of the Utrecht Health Project.
  • Having a signed written UHP informed consent, allowing follow-up through
  • linkage with registries and sharing information across medical professionals.
  • Indicated in UHP informed consent to be interested in participating in
  • further research.
  • Having had blood samples stored in the UHP biobank.

排除标准

  • Receiving major (cardiovascular) surgery, and/or revascularisation therapy
  • and/or transplantation treatment within 3 months after enrolment.
  • Below the age of 40 years and above 84.
  • Not willing to give written informed consent for UHP-UCC.
  • Not allowing incidental findings to be reported.
  • If the patient gives broad consent, the patient allows to be informed about
  • findings that may be important for him/her. If the patient and/or his
  • representative refuse to agree on this, the patient will not be included.

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验

招募中
不适用
niversity Medical Centre Utrecht - National collaborative knowledge platform to impact on sex- and gender sensitive cardiovascular medicine - pilotcoronary vasculary dysfunctionfunctional impairment of the small vessels of the heart and/or temporary spasm of vessels of the heart10011082
NL-OMON51881niversitair Medisch Centrum Utrecht50
进行中(未招募)
不适用
Project on the promotion of cardiovascular risk evaluation in clinical practice and the assessment of cardiovascular risk evolution after the introduction of a preventive multifactorial strategy aimed at decresing the global risk level (SCORE algorithm), in subjects affected from metabolic syndrome and with a risk level lt; or = 5%Methabolic syndrome (preventive multifactorial strategy aimed at decresing the global risk level) in patients with a risk level ltor = 5%MedDRA version: 6.1Level: PTClassification code 10052066
EUCTR2004-000829-30-ITOVARTIS FARMA
已完成
不适用
etherlands Heart Foundation Coordinating Study Evaluating Outcomes of Advising and Counselling in Heart FailureHeart disease, heart failureCirculatory SystemHeart failure
ISRCTN98675639niversity Medical Center Groningen (UMCG) (The Netherlands)1,050
招募中
不适用
trecht Cardiovascular Cohort - The Second Manifestations of ARTerial disease StudyMyocardial infarctionVascular disease10003216Stroke
NL-OMON54646niversitair Medisch Centrum Utrecht16,227
招募中
不适用
Cardiovascular prevention: project to improve cooperation between general practitioners and occupational physiciansI25.0Atherosclerotic cardiovascular disease, so described
DRKS00007823Institut für Hausarztmedizin der Universität Bonn250